相关实验视频

Updated: Jan 18, 2026

Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation

Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation

Published on: June 26, 2018

α-Synuclein聚合物通过隔离和附带降解来抑制ESCRT-III

Cole S Sitron¹, Victoria A Trinkaus¹, Ana Galesic²

¹Department of Cellular Biochemistry, Max Planck Institute of Biochemistry, 82152 Martinsried, Germany; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, USA; Munich Cluster for Systems Neurology (SyNergy), 81377 Munich, Germany.

|September 11, 2025

概括

阿尔法同核素纤维素触发ESCRT-III蛋白质的附带降解,这是细胞修复的关键组成部分. 这种自我延续的循环驱动着帕金森病的病理学.

科学领域:

神经科学是一个神经科学.
细胞生物学细胞生物学
生物化学生物化学

背景情况:

阿尔法-同核素聚合是帕金森病和同核素病变的核心.
细胞外的α-synuclein纤维进入细胞和种子聚合,隔离细胞蛋白.
隔离蛋白质,特别是ESCRT-III的毒性影响尚不清楚.

研究的目的:

为了研究alpha-synuclein纤维素影响细胞蛋白质平衡的有毒机制.
为了阐明α-synuclein纤维和需要运输 (ESCRT-III系统) 的内体组分复合体之间的相互作用.
了解ESCRT-III封存在驱动疾病进展中的作用.

主要方法:

利用细胞模型研究α-synuclein纤维的吸收和细胞内影响.
采用体外溶解试验来确定分子相互作用.
分析了蛋白质降解途径,特别是蛋白质体破坏.

主要成果:

阿尔法-同核蛋白纤维结合到ESCRT-III蛋白中的一个保存的阿尔法螺旋.
这种相互作用导致"附带降解"和ESCRT-III蛋白池的耗尽.
失去ESCRT-III功能会损害内分泌体膜的修复,促进进一步的聚合.

结论:

附带降解和自我延续的封存系统是蛋白质毒性的关键机制.
阿尔法同核素对ESCRT-III系统的破坏有助于帕金森病的发病.
针对这些封存诱导的毒性途径可能提供治疗策略.

关键词:

在CHMP2B的研究中,这是ESCRT的特色.这是ESCRT-III.帕金森病是帕金森氏症的一种疾病.聚合方式聚合方式聚合方式 lysosome 溶解酶体是如何形成的蛋白质聚合物蔓延扩散蛋白质稳定症是一种蛋白质稳定症.封存是一种封存.α-synuclein 是一种同核蛋白.

更多相关视频

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species

Published on: February 27, 2018

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Published on: May 30, 2015

相关概念视频

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

Export of Misfolded Proteins out of the ER

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...